2nd generation glucose kinase activator (Hua Medicine)

N/A

Report date: 2024/04/28 14:20:51
NME

Base Information

Drug Name2nd generation glucose kinase activator (Hua Medicine)
Drug Alias Name2nd Generation GKA (Hua Medicine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesHualing Pharmaceutical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualing Pharmaceutical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A